Company Filing History:
Years Active: 1992-1995
Title: Kurt R Zinn: Innovator in Radionuclide Separation and Radiation Therapy
Introduction
Kurt R Zinn is a notable inventor based in Columbia, MO (US), recognized for his contributions to the field of radionuclide separation and radiation therapy. With a total of 3 patents, Zinn has made significant advancements that have implications in medical treatments and research.
Latest Patents
Zinn's latest patents include a process for separating a radionuclide from a solution. This innovative process focuses on separating radioactive Cu-64 from a mixture containing both the radionuclide and a precursor element. By preparing a weak acid solution that contains this mixture, Zinn's method utilizes a ligand that preferentially forms a complex with the radionuclide, allowing for effective separation. Another significant patent is for a radiolabeled protein composition and method for radiation synovectomy. This composition is designed for radiation therapy and includes a radioisotope combined with protein material that contains amino acids with sulfhydryl-containing side chains. The method involves administering rhenium radiolabeled protein microspheres to treat arthritic joints.
Career Highlights
Zinn is affiliated with the University of Missouri, where he continues to contribute to research and innovation in his field. His work has not only advanced scientific understanding but has also provided practical applications in medical therapies.
Collaborations
Zinn has collaborated with notable colleagues such as Gary J Ehrhardt and Robert K Guimon, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Kurt R Zinn's innovative work in radionuclide separation and radiation therapy exemplifies the importance of research in advancing medical treatments. His patents reflect a commitment to improving healthcare through scientific innovation.